CCL2 and COVID-19: VEGF, TSLP, and CCL17 concentrations were unchanged over time in patients with COVID-19, remaining lower than those measured in healthy volunteers, but CCL2 and IL-10 concentrations significantly reduced further compared with day 14 (figure 1C and figure 1D).